Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection-Reference-Cited by-同舟云学术

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection

Published:2019-04-04 Issue:4 Volume:14 Page:e0214613
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jeon Mi Young,Kim Hye Soo,Lim Tae Seop,Han Dai Hoon,Kim Beom Kyung,Park Jun Yong,Kim Do Young,Ahn Sang Hoon,Choi Gi Hong,Choi Jin Sub,Han Kwang-Hyub,Kim Seung Up^ORCID

Funder

National Research Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Global cancer statistics, 2012;LA Torre;CA: a cancer journal for clinicians,2015

2. Correlation of solid dosage porosity and tensile strength with acoustically extracted mechanical properties;X Xu;International journal of pharmaceutics,2018

3. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma;BK Kim;Journal of hepatology,2015

4. Transarterial chemoembolization versus resection for intermediate-stage;JY Kim;Clinical and molecular hepatology,2016

5. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naive patients with hepatocellular carcinoma;BK Kim;Liver international: official journal of the International Association for the Study of the Liver,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined image-guided radiofrequency and iodine-125 seeds implantation in the treatment of recurrent hepatocellular carcinoma after hepatectomy;BMC Cancer;2024-05-31

2. Transarterial Chemoembolization in Therapy of Patients with Recurrence of Hepatocellular Cancer in a Liver Transplant: a Clinical Case;Journal of oncology: diagnostic radiology and radiotherapy;2023-10-16

3. Recent advances in recurrent hepatocellular carcinoma therapy;World Journal of Hepatology;2023-04-27

4. Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization;Medicina;2022-09-24

5. Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma;BMC Cancer;2022-03-14